We are live on ! Find out more
JCM

Jacobi Capital Management Portfolio holdings

AUM $2.04B
1-Year Est. Return 26.26%
This Fund
S&P 500
This Quarter Est. Return
+15.61%
1 Year Est. Return
+26.26%
3 Year Est. Return
+76.57%
5 Year Est. Return
+89.08%
10 Year Est. Return
+253.33%
AUM
$535M
AUM Growth
+$69.6M
Cap. Flow
+$15.4M
Cap. Flow %
2.88%
Top 10 Hldgs %
37.7%
Holding
1,312
New
118
Increased
403
Reduced
184
Closed
45

Top Buys

Rank Stock Value
1
PBND
Invesco PureBeta US Aggregate Bond ETF
PBND
+$11.2M
2
SPAB icon
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
+$4.41M
3
SPTI icon
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
+$4.38M
4
SUSA icon
iShares ESG Optimized MSCI USA ETF
SUSA
+$2.79M
5
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$2.5M

Top Sells

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$11.9M
2
IYR icon
iShares US Real Estate ETF
IYR
+$5.35M
3
SPTM icon
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
+$4.2M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.99M
5
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$1M

Sector Composition

Rank Sector Weight
1 Financials 10.6%
2 Healthcare 8.71%
3 Technology 8.09%
4 Consumer Staples 5.41%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCR
1301
DELISTED
Hi-Crush Inc. Common Stock
HCR
$0 ﹤0.01%
100
– –
CHK
1302
DELISTED
Chesapeake Energy Corporation
CHK
– –
-4
Closed –
AGN
1303
DELISTED
Allergan plc
AGN
– –
-1,655
Closed -$293K
NTGN
1304
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
– –
-500
Closed -$1K
S
1305
DELISTED
Sprint Corporation
S
– –
-3,590
Closed -$31K
NVIV
1306
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
– –
0
– –
CRC
1307
DELISTED
California Resources Corporation
CRC
$0 ﹤0.01%
21
-1
-5% -$2
CPAH
1308
DELISTED
Counterpath Corp
CPAH
$0 ﹤0.01%
20
– –
SBNY
1309
DELISTED
Signature Bank
SBNY
– –
-300
Closed -$24K
VVUS
1310
DELISTED
Vivus Inc
VVUS
$0 ﹤0.01%
24
– –
FTR
1311
DELISTED
Frontier Communications Corp.
FTR
– –
-698
Closed –
AIM
1312
AIM ImmunoTech
AIM
$7.29M
– –
0
– –
49 50 51 52
53

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return

Jacobi Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Jacobi Capital Management held 1,312 positions worth $535M, up 15% from $465M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Jacobi Capital Management's Q2 2020 filing shows 118 new, 403 increased, 184 reduced and 45 closed positions. Its largest new stake was Invesco PureBeta US Aggregate Bond ETF: 419,696 shares worth $11.3M. The largest sale was Vanguard FTSE All-World ex-US ETF, an estimated $11.9M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Technology.

  • Jacobi Capital Management's largest Q2 2020 buy was Invesco PureBeta US Aggregate Bond ETF: 419,696 shares worth $11.3M.
  • Jacobi Capital Management added most to State Street SPDR Portfolio Aggregate Bond ETF in Q2 2020, an estimated $4.41M increase.
  • Jacobi Capital Management's biggest Q2 2020 reduction was Vanguard FTSE All-World ex-US ETF, cutting an estimated $11.9M.
  • Jacobi Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $293K.
  • Jacobi Capital Management's ten largest holdings make up 38% of its $535M portfolio in Q2 2020.
  • Jacobi Capital Management opened 118 new positions and closed 45 in Q2 2020.
  • Jacobi Capital Management's portfolio value rose 15% quarter-over-quarter to $535M.

Based on Jacobi Capital Management's 13F filing for Q2 2020, filed 27 Jul 2020.